News Quantified

OGEN – oragenics inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Form SC 13G/A ORAGENICS INC Filed by: Lind Global Fund II LP

Form SC 13G/A ORAGENICS INC Filed by: Iroquois Capital Management, LLC

Form 10-Q ORAGENICS INC For: Sep 30

Form DEFA14A ORAGENICS INC

Form DEF 14A ORAGENICS INC For: Oct 31

Top News Gainers

5/4 Oragenics Acquires Noachis Terra Inc., To Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing “Spike Protein” 56.0%

9/6 Form 8-K ORAGENICS INC For: Sep 06 21.4%

6/24 Form S-8 ORAGENICS INC 15.7%

5/20 Oragenics, Inc. Provides Development Update of AG013 for Oral Mucositis 13.8%

9/23 Oragenics, Inc. to Present Interim Data on AG013 at the European Society of Medical Oncology Congress 13.2%

2/7 Oragenics, Inc. to Present at the 22nd Annual BIO CEO & Investor Conference 7.5%

11/15 Oragenics, Inc. Publishes Peer-Reviewed Study in Journal of Peptide Science Demonstrating First Complete Chemical Synthesis of Bicyclic Ring of a Mutacin 1140 Analog 5.6%

11/11 Oragenics, Inc. SVP of Discovery Research, Martin Handfield, Ph.D. to Be Featured Speaker at the International Conference on Microbial Research and Applications 3.5%

3/2 Form SC 13D/A ORAGENICS INC Filed by: KIRK RANDAL J 2.8%

9/25 Oragenics, Inc. Announces Phase 2 Clinical Trial of AG013 Reaches Enrollment of 158 Patients 2.7%

Top News Decliners

10/22 Form 8-K ORAGENICS INC For: Oct 22 -20.0%

2/11 Form SC 13G/A ORAGENICS INC Filed by: INTRACOASTAL CAPITAL, LLC -10.4%

12/3 Oragenics Inc. to Present at the LD Micro 12th Annual Main Event on December 10, 2019 -6.9%

2/7 Form 4 ORAGENICS INC For: Feb 05 Filed by: KOSKI ROBERT C -6.5%

3/4 Form 10-K ORAGENICS INC For: Dec 31 -4.9%

9/30 Oragenics Presents Interim Data on The AG013 Phase 2 Clinical Trial at the European Society for Medical Oncology Congress 2019 -4.6%

9/25 Form 8-K ORAGENICS INC For: Sep 25 -4.3%

12/2 Oragenics, Inc. Announces Completion of Enrollment of Its Phase 2 Clinical Trial for AG013 in Oral Mucositis -3.2%

1/24 Form SC 13D/A ORAGENICS INC Filed by: KOSKI FAMILY LP -3.2%

12/4 Form 8-K ORAGENICS INC For: Dec 04 -3.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day